Overview
- Legal name
- GENOMIC LABS LTD
- Registered location
- BRISTOL, GBR
- Website
- Company website ↗
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- Latest award activity
- Sep 29, 2025
Read company summary
GENOMIC LABS LTD is associated with UEI NGZ6HVXE5MX4 and CAGE U1PX6 in public federal records. AcornBids currently links 1 prime award totaling $1.0M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)). Its public SAM.gov registration lists BRISTOL, GBR.
At a glance
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 28, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- GENOMIC LABS LTD
- UEI
- NGZ6HVXE5MX4
- CAGE
- U1PX6
- Registered address
- SCIENCE CREATES OLD MARKET, BRISTOL, BS2 0JZ, GBR
- Registration status
- Active
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- SAM activation
- Apr 13, 2026
- Initial registration
- Sep 7, 2020
- Entity start
- Aug 12, 2019
- SAM updated
- Apr 13, 2026
- Registration expires
- Apr 13, 2027
- Fiscal year end
- Aug 31
- Place of incorporation
- GBR
Federal award analysis
Net transaction obligations by federal fiscal period.
Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 75N93025C00025TO DEVELOP AN INTEGRATED DIAGNOSTIC PLATFORM THAT UTILIZES WHOLE GENOME SEQUENCING (WGS) TO IDENTIFY BACTERIAL PATHOGENS AND PREDICT ANTIBIOTIC SUSCEPTIBILITY DIRECTLY FROM… | Department of Health and Human Services | $1.0M | Sep 29, 2025 | May 31, 2027 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Apr 13, 2026 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Sep 7, 2020 |
| Entity start | Aug 12, 2019 |
| Industry | Reported size status |
|---|---|
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| BEN HADLOW | Government business | Contact method not published | SAM registration | Not available |
| BEN HADLOW | Electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
No official subaward rows are loaded, so Acorn does not claim known teaming relationships.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit